1. Home
  2. DNLI vs BTE Comparison

DNLI vs BTE Comparison

Compare DNLI & BTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • BTE
  • Stock Information
  • Founded
  • DNLI 2013
  • BTE 1993
  • Country
  • DNLI United States
  • BTE Canada
  • Employees
  • DNLI N/A
  • BTE N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • BTE Meat/Poultry/Fish
  • Sector
  • DNLI Health Care
  • BTE Consumer Staples
  • Exchange
  • DNLI Nasdaq
  • BTE Nasdaq
  • Market Cap
  • DNLI 2.2B
  • BTE 1.8B
  • IPO Year
  • DNLI 2017
  • BTE N/A
  • Fundamental
  • Price
  • DNLI $14.85
  • BTE $2.33
  • Analyst Decision
  • DNLI Strong Buy
  • BTE
  • Analyst Count
  • DNLI 13
  • BTE 0
  • Target Price
  • DNLI $32.64
  • BTE N/A
  • AVG Volume (30 Days)
  • DNLI 1.5M
  • BTE 21.4M
  • Earning Date
  • DNLI 11-03-2025
  • BTE 10-30-2025
  • Dividend Yield
  • DNLI N/A
  • BTE 2.76%
  • EPS Growth
  • DNLI N/A
  • BTE N/A
  • EPS
  • DNLI N/A
  • BTE 0.20
  • Revenue
  • DNLI N/A
  • BTE $2,194,819,404.00
  • Revenue This Year
  • DNLI N/A
  • BTE N/A
  • Revenue Next Year
  • DNLI $94,232.03
  • BTE N/A
  • P/E Ratio
  • DNLI N/A
  • BTE $11.86
  • Revenue Growth
  • DNLI N/A
  • BTE N/A
  • 52 Week Low
  • DNLI $10.57
  • BTE $1.36
  • 52 Week High
  • DNLI $33.33
  • BTE $3.18
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 42.38
  • BTE 49.29
  • Support Level
  • DNLI $15.53
  • BTE $2.27
  • Resistance Level
  • DNLI $17.02
  • BTE $2.43
  • Average True Range (ATR)
  • DNLI 0.75
  • BTE 0.08
  • MACD
  • DNLI -0.23
  • BTE 0.00
  • Stochastic Oscillator
  • DNLI 9.18
  • BTE 56.61

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About BTE Baytex Energy Corp

Baytex Energy Corp is an oil and gas company. Geographically, the group operates in Canada and the United States. The company derives a majority of revenue from Canada. Its Canada segment includes the exploration, development, and production of crude oil and natural gas in Western Canada.

Share on Social Networks: